This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Eissenberg, L G Articles by Goldman, W E Search for Related Content PubMed PubMed Citation Articles by Eissenberg, L G Articles by Goldman, W E

 Previous Article  |  Next Article 

Infect Immun. 1987 January; 55(1): 29-34

Histoplasma capsulatum fails to trigger release of superoxide from macrophages.

ABSTRACT

The yeast form of the dimorphic fungus Histoplasma capsulatum survives within macrophages after phagocytosis. To do so, it must avoid, inhibit, or resist a variety of toxic oxygen metabolites. Using ferricytochrome c reduction to assay superoxide release, we examined the response of mouse macrophages to the yeast form of various H. capsulatum strains. Doses of zymosan as low as 20 particles per macrophage elicited superoxide, whereas H. capsulatum failed to induce superoxide even at 160 yeast cells per macrophage. This phenomenon was observed with two virulent strains of H. capsulatum (G217B and G186A) and with an avirulent variant of G186A. Over a 15- to 150-min observation period, zymosan stimulated increasing reduction of ferricytochrome c, but H. capsulatum did not. When added concurrently with zymosan, H. capsulatum had no effect on superoxide production. Therefore, H. capsulatum was unable either to inactivate the oxygen radical or inhibit host cell superoxide response to other competent stimuli. Enzymatically generated superoxide reduced ferricytochrome c even in the presence of H. capsulatum, again implying that the organism does not readily inactivate superoxide. This experiment also demonstrated that the yeast did not interfere with the assay used. Thus, rather than inhibiting superoxide generation or inactivating the anion, H. capsulatum yeast cells appear to avoid the toxic effects of superoxide by failing to trigger its release.

This article has been cited by other articles:

• Shi, L., Albuquerque, P. C., Lazar-Molnar, E., Wang, X., Santambrogio, L., Gacser, A., Nosanchuk, J. D. (2008). A Monoclonal Antibody to Histoplasma capsulatum Alters the Intracellular Fate of the Fungus in Murine Macrophages. Eukaryot Cell 7: 1109-1117 [Abstract] [Full Text]  
• Newman, S. L., Gootee, L., Hilty, J., Morris, R. E. (2006). Human Macrophages Do Not Require Phagosome Acidification to Mediate Fungistatic/Fungicidal Activity against Histoplasma capsulatum. J. Immunol. 176: 1806-1813 [Abstract] [Full Text]  
• Deepe, G. S. Jr., Gibbons, R., Woodward, E. (1999). Neutralization of Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Subverts the Protective Immune Response to Histoplasma capsulatum. J. Immunol. 163: 4985-4993 [Abstract] [Full Text]  
• Strasser, J. E., Newman, S. L., Ciraolo, G. M., Morris, R. E., Howell, M. L., Dean, G. E. (1999). Regulation of the Macrophage Vacuolar ATPase and Phagosome-Lysosome Fusion by Histoplasma capsulatum. J. Immunol. 162: 6148-6154 [Abstract] [Full Text]  
• Retallack, D. M., Heinecke, E. L., Gibbons, R., Deepe, G. S. Jr., Woods, J. P. (1999). The URA5 Gene Is Necessary for Histoplasma capsulatum Growth during Infection of Mouse and Human Cells. Infect. Immun. 67: 624-629 [Abstract] [Full Text]